|4.08|| +0.02 / +0.49%|
iCAD, Inc. is a provider of advanced image analysis and workflow solutions for the early identification of cancer. The company operates its business through two segments: Cancer Detection and Cancer Therapy. The Cancer Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the most prevalent cancers earlier, a comprehensive range of high-performance, upgradeable Computer-Aided Detection systems and workflow solutions for mammography, Magnetic Resonance and Computed Tomography CT. The Cancer Therapy segment offers an isotope-free cancer treatment platform technology. iCAD was founded in 1984 and is headquartered in Nashua, NH.
|Kenneth M. Ferry||Chief Executive Officer & Director|
|Kevin C. Burns||President, COO, CFO, Secretary, Treasurer & EVP|
|Jonathan Go||Senior Vice President-Research & Development|
|John A. DeLucia||VP-Regulatory Affairs & Clinical Affairs|
|Kamal C. Gogineni||Senior Vice President-Oncology Solutions|